胆固醇酯转运蛋白抑制剂就是一种这一类型的药，它可以减少“坏”的胆固醇(低密度脂蛋白)，同时增加“好”的胆固醇(高密度脂蛋白)。
One such type of drug is called a CETP inhibitor, intended to reduce "bad" cholesterol (LDL) and raise "good" cholesterol (HDL).
综述了胆固醇生物合成过程及生物合成过程中关键酶抑制剂的研究开发现状。
Cholesterol biosynthetic pathway, status of research and development on inhibitors of key enzymes in cholesterol biosynthesis were reviewed.
美伐他汀是3羟甲基戊二酰辅酶a还原酶的有效的竞争性抑制剂，它是一种胆固醇生物合成调解酶。
Mevastatin is a potent competitive inhibitor of 3-hydroxy-3-methyl-glutaryl-coa reductase, a regulatory enzyme for cholesterol biosynthesis.
美伐他汀是3羟甲基戊二酰辅酶a还原酶的有效的竞争性抑制剂，它是一种胆固醇生物合成调解酶。
Mevastatin is a potent competitive inhibitor of 3-hydroxy-3-methyl-glutaryl (HMG) -coa reductase, a regulatory enzyme for cholesterol biosynthesis.
抑制胆固醇脂转移蛋白是否具有潜在获益，尚有待其他不升高血压的新CETP抑制剂的进一步研究结果来证实。
Whether inhibition of cholesteryl ester transfer protein is potentially beneficial awaits results from further studies with other new CETP inhibitors that do not cause elevated blood pressure.
抑制胆固醇脂转移蛋白是否具有潜在获益，尚有待其他不升高血压的新CETP抑制剂的进一步研究结果来证实。
Whether inhibition of cholesteryl ester transfer protein is potentially beneficial awaits results from further studies with other new CETP inhibitors that do not cause elevated blood pressure.
应用推荐